141 related articles for article (PubMed ID: 2184824)
1. [Pancreatic enzyme substitution in patients with mucoviscidosis].
Henker J
Gastroenterol J; 1990; 49(4):151-5. PubMed ID: 2184824
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
Gottschalk B; Wiesemann HG; Stephan U
Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
Henker J; Hoffmann D; Paul D; Hein J; Paditz E
Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
[TBL] [Abstract][Full Text] [Related]
4. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
Löser C; Fölsch UR
Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
[TBL] [Abstract][Full Text] [Related]
7. [Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation].
Freise J; Horstkotte H
Fortschr Med; 1986 Sep; 104(33):625-8. PubMed ID: 3639835
[No Abstract] [Full Text] [Related]
8. Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis.
Walkowiak J; Lisowska A
J Pediatr; 2005 Dec; 147(6):870-1. PubMed ID: 16356455
[No Abstract] [Full Text] [Related]
9. [Pancreatic enzyme replacement in mucoviscidosis (CF): clinical evaluation of a gastric acid-resistant pancreatin preparation in encapsulated microtablet form].
Stern M; Plettner C; Grüttner R
Klin Padiatr; 1988; 200(1):36-9. PubMed ID: 2452915
[TBL] [Abstract][Full Text] [Related]
10. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
Santini B; Ivaldi AP
Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
[TBL] [Abstract][Full Text] [Related]
11. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
Heijerman HG
Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
[TBL] [Abstract][Full Text] [Related]
12. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment.
Bruno MJ; Haverkort EB; Tytgat GN; van Leeuwen DJ
Am J Gastroenterol; 1995 Sep; 90(9):1383-93. PubMed ID: 7661155
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
[No Abstract] [Full Text] [Related]
14. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
15. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
Simek I; Kubias K; Duda M
Acta Physiol Hung; 1992; 80(1-4):417-21. PubMed ID: 1364280
[TBL] [Abstract][Full Text] [Related]
16. Nutritional management of cystic fibrosis patients.
Kalnins D; Durie PR; Pencharz P
Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):348-54. PubMed ID: 17414506
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of panzytrat--modern physiological enzyme preparation in complex therapy of pancreatic exocrine secretory insufficiency in cholelithiasis].
Petukhov VA; Mironov AV; Semenov ZhS; Ustinov FS
Eksp Klin Gastroenterol; 2009; (1):72-80. PubMed ID: 19551960
[TBL] [Abstract][Full Text] [Related]
18. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
Dutta SK; Tilley DK
J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
[No Abstract] [Full Text] [Related]
19. [Therapy with pancreatic enzyme preparations].
Holtmann G; Layer P
Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
[No Abstract] [Full Text] [Related]
20. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
